Leiderman Elisabeth
- SEC CIK
- 0001842133
No open-market purchases or sales filed in the past year.
Current role at each company
- AUTL Autolus Therapeutics plcDirectoras of Jul 1, 2026
- BLUE bluebird bio, Inc.Directoras of Jun 3, 2025
- DBTX Decibel Therapeutics, Inc.Chief Financial Officeras of Feb 28, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Leiderman Elisabeth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BLUE bluebird bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 (view filing) | Oct 17, 2022 | 143 daysLate | Leiderman ElisabethDirector | SSale | −1.00K | $6.46 | −$6.49K | −8.1%11.5K after |